SEC Form 4 · accession 0001209191-15-045949
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew A. Ankrum
Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.00 | May 20, 2015 | A | 15,000 | A | — | May 14, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments on May 14, 2016, 2017, and 2018.